Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = carcinomatous cirrhosis

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
6 pages, 1537 KiB  
Case Report
Medullary Thyroid Cancer and Pseudocirrhosis: Case Report and Literature Review
by B.L. Harry, M.L. Smith, J.R. Burton, A. Dasari, S.G. Eckhardt and J.R. Diamond
Curr. Oncol. 2012, 19(1), 36-41; https://doi.org/10.3747/co.19.840 - 1 Feb 2012
Cited by 24 | Viewed by 1010
Abstract
Pseudocirrhosis is a rare form of liver disease that can cause clinical symptoms and radiographic signs of cirrhosis; however, its histologic features suggest a distinct pathologic process. In the setting of cancer, hepatic metastases and systemic chemotherapy are suspected causes of pseudocirrhosis. Here, [...] Read more.
Pseudocirrhosis is a rare form of liver disease that can cause clinical symptoms and radiographic signs of cirrhosis; however, its histologic features suggest a distinct pathologic process. In the setting of cancer, hepatic metastases and systemic chemotherapy are suspected causes of pseudocirrhosis. Here, we present a patient with medullary thyroid carcinoma metastatic to the liver who developed pseudocirrhosis while on maintenance sunitinib after receiving 5-fluorouracil, leucovorin, and oxaliplatin (folfox) in combination with sunitinib. Cirrhotic change in liver morphology was accompanied by diffusely infiltrative carcinomatous disease resembling the primary tumor. We discuss the diagnosis of pseudocirrhosis in this case and review the literature regarding pseudocirrhosis in cancer. Full article
Back to TopTop